HIV Prevention Research Division (UPenn)

HIV Prevention Research Division (UPenn) Currently recruiting healthy individuals (ages 18-50) to participate in a clinical trial. Compensation for time and travel.

Visit PhillyLHIVE.org or call/text (215) 821-7562 The HIV Prevention Research Division designs, implements and tests behavioral and biomedical interventions for safety and efficacy.

Happy Memorial Day everyone! Today we remember and honor the fallen....
05/25/2026

Happy Memorial Day everyone! Today we remember and honor the fallen....

Congrats to our CTU CAB on the success of their first Annual Community Wellness Day in partnership with the CFAR CAB....
05/11/2026

Congrats to our CTU CAB on the success of their first Annual Community Wellness Day in partnership with the CFAR CAB....

UPENN Nurses.6th Annual Community Wellness.Day!
05/03/2026

UPENN Nurses.6th Annual Community Wellness.Day!

Please join us on Saturday, May 9th from 11am to 3pm at Mt. Pisgah AME for our Community Wellness Day presented by UPENN...
04/28/2026

Please join us on Saturday, May 9th from 11am to 3pm at Mt. Pisgah AME for our Community Wellness Day presented by UPENN's CTU CAB and CFAR CAB! Come out and learn all about the comprehensive health resources available to all Philadelphians!

Join as this Saturday, February 7th, from 12pm to 5 pm for a day of "care, connection and community" at the THRIVE Welln...
02/04/2026

Join as this Saturday, February 7th, from 12pm to 5 pm for a day of "care, connection and community" at the THRIVE Wellness Expo and Marketplace brought to you by WELL.YES Philadelphia Task Force and Philadelphia Black Pride at the Philadelphia Ethical Society (1906 Rittenhouse Square). See the flyer for all the incredible things you can expect to see there!

A huge step in the process of finding a cure for HIV..  "It’s also important to point out that cancer-free people with H...
12/03/2025

A huge step in the process of finding a cure for HIV..

"It’s also important to point out that cancer-free people with HIV won’t benefit from stem cell transplants, as it’s a very risky procedure that can lead to life-threatening infections, says Gaebler. Most people are better off taking ART – often in the form of daily pills – which is a much safer and convenient way to stop HIV from spreading, enabling people to enjoy long and healthy lives, he says. Moreover, a recently available drug called lenacapavir provides nearly complete protection against HIV with just two injections per year.

https://www.newscientist.com/article/2506595-man-unexpectedly-cured-of-hiv-after-stem-cell-transplant/?fbclid=IwdGRzaAOcqSJjbGNrA5ypEmV4dG4DYWVtAjExAHNydGMGYXBwX2lkDDM1MDY4NTUzMTcyOAABHpVo63g_rBOeHM3wNOoAkhiz70sMgXIiiiCJbJYqaoEmgRlnVbJatS8WM2WY_aem_ramomUfTcgLb36vGWsiRMA&brid=FiUDhSJHp4TjVgiDWU1v2Q

A handful of people with HIV have been cured after receiving HIV-resistant stem cells – but a man who received non-resistant stem cells is also now HIV-free

Today we celebrate World AIDS Day....remembering those we lost and those living bravely with HIV...
12/01/2025

Today we celebrate World AIDS Day....remembering those we lost and those living bravely with HIV...

The impact of federal research dollars:-Research funded by the National Institutes of Health (NIH) played a role in more...
07/21/2025

The impact of federal research dollars:
-Research funded by the National Institutes of Health (NIH) played a role in more than 99 percent of the 356 new drugs approved by the Food and Drug Administration (FDA) between 2010-2019
-$1 NIH funding = $2.56 in economic activity
-In FY2024, Pennsylvania ranked in the nation’s top 5 for NIH award totals and top 3 for related economic activity
-In FY2024, NIH grants and contracts supported nearly 22,000 jobs and more than $5 billion in economic activity in Pennsylvania

Public investments in biomedical research have an outsized effect, driving new scientific insights, economic growth, and ultimately treatments and cures.

Exciting news in the world of HIV prevention!!! We are one of the sites who conducted the clinical trial for this study ...
12/11/2024

Exciting news in the world of HIV prevention!!! We are one of the sites who conducted the clinical trial for this study and we wanted to once again give a huge standing ovation to our volunteers who participated in this study by giving their time and energies to do so! You should be so very proud for making a remarkable difference in the world as we move one step closer to world free from HIV!

A new injectable drug for HIV prevention, lenacapavir, is being hailed as a potential game-changer in the fight against the virus.

Address

3535 Market Street, 4th Floor
Philadelphia, PA
19104

Opening Hours

Monday 9am - 4pm
Tuesday 9am - 4pm
Wednesday 9am - 4pm
Thursday 9am - 4pm
Friday 9am - 4pm

Telephone

+12158217562

Alerts

Be the first to know and let us send you an email when HIV Prevention Research Division (UPenn) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to HIV Prevention Research Division (UPenn):

Share